Publications

2018

Ippoliti M, Adams LC, Winfried B, Hamm B, Spincemaille P, Wang Y, et al. Quantitative susceptibility mapping across two clinical field strengths: Contrast-to-noise ratio enhancement at 1.5T. J Magn Reson Imaging. 2018;48(5):1410-1420.
Kim Y, Zhang Z, Shim J-, Lee TS, Tung C-. A cell surface clicked navigation system to direct specific bone targeting. Bioorg Med Chem. 2018;26(3):758-764.
Zhang J, Cho J, Zhou D, Nguyen TD, Spincemaille P, Gupta A, et al. Quantitative susceptibility mapping-based cerebral metabolic rate of oxygen mapping with minimum local variance. Magn Reson Med. 2018;79(1):172-179.
Aaron RK, Racine JR, Voisinet A, Evangelista P, Dyke JP. Subchondral bone circulation in osteoarthritis of the human knee. Osteoarthritis Cartilage. 2018;26(7):940-944.
Amor-Coarasa A, Kelly J, Ponnala S, Vedvyas Y, Nikolopoulou A, Williams C, et al. [F]RPS-544: A PET tracer for imaging the chemokine receptor CXCR4. Nucl Med Biol. 2018;60:37-44.
Fortea J, Carmona-Iragui M, Benejam B, Fernández S, Videla L, Barroeta I, et al. Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study. Lancet Neurol. 2018;17(10):860-869.
Kommidi H, Tosi U, Maachani UB, Guo H, Marnell CS, Law B, et al. F-Radiolabeled Panobinostat Allows for Positron Emission Tomography Guided Delivery of a Histone Deacetylase Inhibitor. ACS Med Chem Lett. 2018;9(2):114-119.
Illán-Gala I, Pegueroles J, Montal V, Vilaplana E, Carmona-Iragui M, Alcolea D, et al. Challenges associated with biomarker-based classification systems for Alzheimer's disease. Alzheimers Dement (Amst). 2018;10:346-357.

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065